Clinical Trial Update: Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of five antipsychotic medications in psychiatric participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• Multiple antipsychotic medications (Phase 1 PK study)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Psychotic Disorders, Schizophrenia | Phase 1 | Status: COMPLETED